documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

14 rows where docket_id = "FDA-2006-N-0304" and posted_year = 2010 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), last_modified (date)

document_type 4

posted_year 1

  • 2010 · 14 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-N-0304-0051 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Use of Ozone-Depleting Substances: Removal of Essential-Use Designation (Flunisolide, etc.); Correction Notice NCR-Notice of Correction 2010-09-17T04:00:00Z 2010 9 2010-09-17T04:00:00Z   2011-06-11T16:25:59Z 2010-23195 0 0 0900006480b51d24
FDA-2006-N-0304-0050 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 OMB Changes, Executive Order 12866 (E.O.) [Use of Ozone-Depleting Substances; Removal of Essential-Use Designations (Flunisolide, etc.)] - Reference Other REF-Reference Material (internal attachments) 2010-04-27T04:00:00Z 2010 4 2010-04-27T04:00:00Z   2013-07-27T23:17:05Z   0 0 0900006480ae1652
FDA-2006-N-0304-0045 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 07 - U.S. Environmental Protection Agency. "The Benefits and Costs of the Clean Air Act: 1990-2010" [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:58Z   0 0 0900006480ad651c
FDA-2006-N-0304-0040 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 List of References - [FDA-2006-N-0304 Notice of Final Rule 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:50Z   0 0 0900006480ad5ea8
FDA-2006-N-0304-0044 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 06 - United Nations Environmental Programme, Production and Consumption of Ozone-Depleting Substances: 1986-2004, 2005. [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:56Z   0 0 0900006480ad651b
FDA-2006-N-0304-0043 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 04 - Envrios March, Study on the Use of HFCs for Metered Dose Inhalers In the European Union: Final report following submission to the ECCP (European Commission Climate Change Policy Group) [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:55Z   0 0 0900006480ad5eac
FDA-2006-N-0304-0042 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 03 - US Department of Commerce, Census Bureau; Economics and Statistics Administration, Pharmaceutical Preparation Manufacturing: 2002 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:53Z   0 0 0900006480ad5eab
FDA-2006-N-0304-0049 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 15 - DeNavas-Walt, C. B. D. Proctor, and J. C Smith, U.S. Census Bureau, Current Population Reports, P60-236(RV), Income, Poverty, and Health Insurance Coverage in the United States: 2008, Table 7, p. 21. 2009 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:51:03Z   0 0 0900006480ad6348
FDA-2006-N-0304-0046 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 08 - American Lung Association, "Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality," [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:59Z   0 0 0900006480ad651d
FDA-2006-N-0304-0039 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Use of Ozone-Depleting Substances; Removal of Essential-Use Designation: Flunisolide, etc. Rule NFR-Notice of Final Rule 2010-04-14T04:00:00Z 2010 4 2010-04-14T04:00:00Z   2011-06-11T16:25:59Z 2010-08467 0 0 0900006480ad7218
FDA-2006-N-0304-0041 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 01 - Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma (EPR-3), NIH Publication No. 07-4051 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:50:52Z   0 0 0900006480ad5ea9
FDA-2006-N-0304-0047 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 09 - American Lung Association, "Trends in Asthma Morbidity and Mortality," January 2009 [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:51:01Z   0 0 0900006480ad651e
FDA-2006-N-0304-0048 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Reference 11 - Analysis completed by FDA based on information provided by IMS Health, [FDA-2006-N-0304 Notice of Final Rule, 4/14/2010] Supporting & Related Material BKG-Background Material 2010-04-14T04:00:00Z 2010 4     2010-04-14T14:51:02Z   0 0 0900006480ad6572
FDA-2006-N-0304-0038 FDA Use of Ozone-Depleting Substances; Removal of Essential-Use Designations FDA-2006-N-0304 Graceway Pharmaceuticals, LLC - Supplement Comment re FDA-2006-N-0304-0032 Other SUP-Supplement 2010-02-03T05:00:00Z 2010 2 2010-02-03T05:00:00Z   2013-07-27T23:05:37Z   0 0 0900006480a8731b

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);